Linked Life Data

19180427

Source:http://linkedlifedata.com/resource/pubmed/id/19180427

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-30
pubmed:abstractText
The effects of most prostagens used in hormone replacement therapy (HRT) and in hormonal contraception are not identical. They differ in their structure, the metabolisation, their bioavailability and their partial activities. Therefore, it does not make any sense to declare that the different progestagens with their different profiles belong to one class of substances, having all the same effect. In function of their partial activities, progestagens are used today specifically for HRT, for hormonal contraception or as an anti-androgen. Because of their metabolic profile, some newer progestagens can be considered to be specifically favourable, such as Norpregnanes, Dienogest and Drospirenone. This review summarizes the properties and partial activities of progestagens used today and analyzes its clinical consequences.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0040-5930
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
71-87
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
[Progestagen use in oral contraception - basic knowledge].
pubmed:affiliation
Abteilung für gynäkologische Endokrinologie und Reproduktionsmedizin, Frauenklinik, Universitätsspital Bern. martin.birkhaeuser@balcab.ch
pubmed:publicationType
Journal Article, Comparative Study, English Abstract, Review